1. /
  2. About us /
  3. Our people and structure /
  4. Our people /
  5. Mark A Stoové

Background

Professor Stoové is Head of Public Health at Burnet Institute where he also heads research groups in HIV Prevention and Justice Health. He has undertaken research on the epidemiology and prevention of blood borne viruses and sexually transmitted infections and the health and wellbeing of affected populations for over 20 years. His research focuses is on generating evidence for effective public health policy and practice.

He has strong interests in developing novel and innovative approaches to epidemiological research to inform clinical and public health policy and practice He has led the development and maintenance of innovative sentinel surveillance systems for HIV and other sexually transmitted infections and blood borne viruses in developed and low and middle income countries.

He has also led large bio-behavioural prospective cohort studies of people who inject drugs and other groups disproportionately affected by viral hepatitis, HIV and other sexually transmitted infections. I has helped lead large-scale sexual health and sexually transmitted infection prevention program implementations and randomised controlled trials in Australia and low income settings internationally.

He has published over 200 peer reviewed paper and assumes various editorial roles for international peer review journal editorial roles as well as conference convening roles. Over the past five years he has attracted in excess of AUD$30 million in research funds as a lead investigator.

Qualifications

  • 2004: PhD, Victoria University, Melbourne, Australia.
  • 1999: Grad Dip (Ed) RMIT, Melbourne, Australia
  • 1995: BA AppSci (Hons, First Class), Victoria University, Melbourne, Australia.

Positions

  • 2017: Co-Head, Eliminate HIV sub-Program, Disease Elimination Program, Burnet Institute
  • 2012: Head, HIV Research; Head, Justice Health Research, Burnet Institute
  • 2017: Head of Public Health Discipline, Burnet Institute
  • 2011: Principal for Sexual and Reproductive Health, Burnet Institute
  • 2007-2012: Senior Research Fellow / Head of HIV/STI Research - Centre for Population Health, Burnet Institute, Victoria, Australia
  • 2007-present: Honorary Research Fellow - School of Psychology, Deakin University, Victoria, Australia
  • 2008-present: Adjunct Research Fellow – Department of Epidemiology and Preventive Medicine, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria, Australia

Reports + Policy Briefs

2022 (7)

2021 (7)

Reports and other work

Past projects

View 14 more
Novel Point-of-care Testing for Diagnosis of Active Syphilis in Pregnant Women and Infants in Fiji

Novel Point-of-care Testing for Diagnosis of Active Syphilis in Pregnant Women and Infants in Fiji

Congenital syphilis (CS), caused by mother-to-child transmission of spirochete bacterium Treponema Pallidum (TP), is a major global health problem associated with substantial morbidity and mortality in children. Without adequate treatment CS causes significant developmental, neurological and musculoskeletal disability in children, and many infected infants will die within the first year of life. In 2016, estimated global incidence for CS was 473 (385-561) cases per 100,000 live births with a total of 661,000 (538,000-784,000) cases, including 355,000 (290,000-419,000) adverse birth outcomes (143,000 stillbirths; 61,000 neonatal deaths; 41,000 preterm/low- birth weight births; and 109,000 infants with clinical CS). Treatment of syphilis is simple, effective and inexpensive; however, definitive diagnosis of active syphilis requires confirmatory testing which requires laboratory facilities, and not always available in many low-resource settings in low and middle-income countries (LMICs). In 40 of the 81 LMICs which account for more than 95 per cent maternal deaths and more than 90 per cent of deaths in children under five years old, 74 per cent of pregnant women who had at least four antenatal care visits were not tested for syphilis. A combination of treponemal and non-treponemal tests is required for diagnosis of active syphilis but there is no point-of-care test (POCT) that can effectively distinguish between past/treated and active syphilis. There is no POCT for diagnosis of CS available on the market.

ACCESS Myanmar: Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar

ACCESS Myanmar: Assessing the feasibility of an integrated HIV cascade of care surveillance system in Myanmar

ACCESS Myanmar will implement and evaluate an electronic health records data linkage system that effectively monitors the progress of patients through HIV testing and treatment episodes of care across a network of partnering community and government services.

CHINA-B study: Cancer information compared to Hepatitis B information to INcreAse hepatitis B testing in Melbourne’s Chinese community

CHINA-B study: Cancer information compared to Hepatitis B information to INcreAse hepatitis B testing in Melbourne’s Chinese community

This pilot and feasibility study aimed to increase hepatitis B testing in Melbourne’s Chinese community.

View 14 more
On this page